Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer (NYSE: PFE) has announced a public webcast featuring a discussion with Albert Bourla, Chairman and CEO, at the TD Cowen 45th Annual Health Care Conference on March 3, 2025, at 10:30 a.m. EST.
The webcast will be accessible through www.pfizer.com/investors, with registration details available immediately. A transcript and replay will be posted within 24 hours after the live discussion and remain accessible for at least 90 days.
The discussion may include forward-looking statements about Pfizer's operating performance, product pipeline, business strategy, COVID-19 response, and ESG priorities. These statements are subject to risks and uncertainties as detailed in Pfizer's Annual Report on Form 10-K and subsequent SEC filings.
Pfizer (NYSE: PFE) ha annunciato un webcast pubblico che presenterà una discussione con Albert Bourla, Presidente e CEO, durante il 45° Congresso Annuale sulla Salute di TD Cowen il 3 marzo 2025, alle 10:30 a.m. EST.
Il webcast sarà accessibile tramite www.pfizer.com/investors, con i dettagli per la registrazione disponibili immediatamente. Un resoconto e una registrazione della discussione saranno pubblicati entro 24 ore dopo l'evento dal vivo e rimarranno accessibili per almeno 90 giorni.
La discussione potrebbe includere dichiarazioni previsionali sulle performance operative di Pfizer, sul portafoglio prodotti, sulla strategia aziendale, sulla risposta al COVID-19 e sulle priorità ESG. Queste dichiarazioni sono soggette a rischi e incertezze come dettagliato nel Rapporto Annuale di Pfizer sul Modulo 10-K e nei successivi documenti SEC.
Pfizer (NYSE: PFE) ha anunciado un webcast público que contará con una discusión con Albert Bourla, Presidente y CEO, en la 45ª Conferencia Anual de Salud de TD Cowen el 3 de marzo de 2025, a las 10:30 a.m. EST.
El webcast será accesible a través de www.pfizer.com/investors, con detalles de registro disponibles de inmediato. Una transcripción y una repetición se publicarán dentro de las 24 horas posteriores a la discusión en vivo y permanecerán accesibles durante al menos 90 días.
La discusión puede incluir declaraciones prospectivas sobre el rendimiento operativo de Pfizer, su cartera de productos, estrategia empresarial, respuesta al COVID-19 y prioridades ESG. Estas declaraciones están sujetas a riesgos e incertidumbres como se detalla en el Informe Anual de Pfizer en el Formulario 10-K y en las presentaciones posteriores a la SEC.
화이자 (NYSE: PFE)는 알버트 불라 회장 겸 CEO와의 논의가 포함된 공개 웹캐스트를 발표했습니다. 이 웹캐스트는 TD Cowen 제45회 연례 의료 회의에서 2025년 3월 3일 오전 10시 30분 EST에 진행됩니다.
웹캐스트는 www.pfizer.com/investors를 통해 접근할 수 있으며, 등록 세부정보는 즉시 제공됩니다. 생방송 후 24시간 이내에 대본과 재방송이 게시되며 최소 90일 동안 접근 가능합니다.
논의에는 화이자의 운영 성과, 제품 파이프라인, 비즈니스 전략, COVID-19 대응 및 ESG 우선 사항에 대한 미래 예측 진술이 포함될 수 있습니다. 이러한 진술은 화이자의 연례 보고서 10-K 양식 및 이후 SEC 제출 문서에 자세히 설명된 위험과 불확실성에 따릅니다.
Pfizer (NYSE: PFE) a annoncé un webcast public comprenant une discussion avec Albert Bourla, Président et CEO, lors de la 45ème Conférence Annuelle sur la Santé de TD Cowen le 3 mars 2025 à 10h30 EST.
Le webcast sera accessible via www.pfizer.com/investors, avec les détails d'inscription disponibles immédiatement. Un compte rendu et une rediffusion seront publiés dans les 24 heures suivant la discussion en direct et resteront accessibles pendant au moins 90 jours.
La discussion pourrait inclure des déclarations prospectives concernant la performance opérationnelle de Pfizer, son portefeuille de produits, sa stratégie commerciale, sa réponse au COVID-19 et ses priorités ESG. Ces déclarations sont soumises à des risques et des incertitudes comme détaillé dans le Rapport Annuel de Pfizer sur le Formulaire 10-K et dans les dépôts SEC ultérieurs.
Pfizer (NYSE: PFE) hat ein öffentliches Webcast angekündigt, das eine Diskussion mit Albert Bourla, Vorsitzender und CEO, auf der 45. jährlichen Gesundheitskonferenz von TD Cowen am 3. März 2025 um 10:30 Uhr EST beinhalten wird.
Das Webcast wird über www.pfizer.com/investors zugänglich sein, die Registrierungsdetails sind sofort verfügbar. Ein Transkript und eine Wiederholung werden innerhalb von 24 Stunden nach der Live-Diskussion veröffentlicht und bleiben mindestens 90 Tage lang zugänglich.
Die Diskussion könnte zukunftsgerichtete Aussagen zu den Betriebsleistungen von Pfizer, dem Produktportfolio, der Geschäftsstrategie, der COVID-19-Reaktion und den ESG-Prioritäten enthalten. Diese Aussagen unterliegen Risiken und Unsicherheiten, die im Jahresbericht von Pfizer auf Formular 10-K und in den nachfolgenden SEC-Einreichungen detailliert beschrieben sind.
- None.
- None.
To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.
The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, including financial guidance and projections; reorganizations; business plans, strategy, goals and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our Environmental, Social and Governance (ESG) priorities, strategies and goals; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
Category: Finance
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224391792/en/
Media Contact:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor Contact:
IR@Pfizer.com
+1 (212) 733-4848
Source: Pfizer Inc.
FAQ
When is Pfizer's (PFE) presentation at the TD Cowen Healthcare Conference in 2025?
How long will the PFE webcast replay be available for viewing?
What topics will be covered in Pfizer's (PFE) TD Cowen conference presentation?
Where can investors access Pfizer's (PFE) TD Cowen conference webcast?
When will the transcript of PFE's TD Cowen conference presentation be available?
